|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Audentes Therapeutics, Inc. (BOLD) |
|
|
$59.97 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
45,860,000 |
| Market
Cap: |
2.75(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$59.97 - $59.97 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-07-03 |
4 |
OE |
$0.78 |
$20,983 |
D/D |
26,901 |
26,901 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-07-02 |
4 |
AS |
$38.33 |
$805,524 |
D/D |
(21,000) |
0 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-07-02 |
4 |
OE |
$0.78 |
$16,380 |
D/D |
21,000 |
1,401 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-07-02 |
4 |
AS |
$38.02 |
$384,067 |
D/D |
(10,000) |
0 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-07-02 |
4 |
OE |
$0.79 |
$7,900 |
D/D |
10,000 |
5,011 |
|
- |
|
| Newman Mary |
SVP, Regulatory Affairs |
• – – |
2018-06-25 |
4 |
AS |
$40.77 |
$348,581 |
D/D |
(8,545) |
0 |
|
- |
|
| Newman Mary |
SVP, Regulatory Affairs |
• – – |
2018-06-25 |
4 |
OE |
$2.19 |
$18,673 |
D/D |
8,545 |
300 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-06-25 |
4 |
AS |
$40.74 |
$531,154 |
I/I |
(13,000) |
52,343 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-06-25 |
4 |
AS |
$40.36 |
$808,344 |
D/D |
(20,000) |
385,799 |
|
- |
|
| Nagler David |
SVP, HR & Corp. Affairs |
• – – |
2018-06-20 |
4 |
AS |
$45.25 |
$226,461 |
D/D |
(5,000) |
0 |
|
- |
|
| Nagler David |
SVP, HR & Corp. Affairs |
• – – |
2018-06-20 |
4 |
OE |
$2.19 |
$10,926 |
D/D |
5,000 |
300 |
|
- |
|
| Holles Natalie C. |
President and COO |
• – – |
2018-06-01 |
4 |
OE |
$2.76 |
$14,073 |
D/D |
5,090 |
25,090 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2018-05-21 |
4 |
AS |
$38.08 |
$774,498 |
D/D |
(20,300) |
0 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2018-05-21 |
4 |
OE |
$0.78 |
$15,834 |
D/D |
20,300 |
6,700 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2018-04-02 |
4 |
AS |
$30.01 |
$21,009 |
D/D |
(700) |
0 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2018-04-02 |
4 |
OE |
$0.78 |
$546 |
D/D |
700 |
700 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-03-29 |
4 |
OE |
$0.79 |
$6,162 |
D/D |
7,800 |
7,800 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-03-27 |
4 |
OE |
$0.79 |
$237 |
D/D |
300 |
300 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-03-26 |
4 |
AS |
$28.28 |
$801,473 |
I/I |
(28,000) |
62,343 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-03-26 |
4 |
AS |
$29.00 |
$585,464 |
D/D |
(20,000) |
405,799 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-03-26 |
4 |
AS |
$30.00 |
$57,000 |
D/D |
(1,900) |
0 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-03-26 |
4 |
OE |
$0.79 |
$1,501 |
D/D |
1,900 |
1,900 |
|
- |
|
| Newman Mary |
SVP, Regulatory Affairs |
• – – |
2018-03-15 |
4 |
AS |
$29.66 |
$303,627 |
D/D |
(10,000) |
0 |
|
- |
|
| Newman Mary |
SVP, Regulatory Affairs |
• – – |
2018-03-15 |
4 |
OE |
$2.19 |
$21,900 |
D/D |
10,000 |
400 |
|
- |
|
| Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2018-03-12 |
4 |
S |
$34.92 |
$629,859 |
I/I |
(18,003) |
3,539,997 |
|
- |
|
162 Records found
|
|
Page 4 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
